BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3387393)

  • 1. [Use of essentiale in chronic liver diseases in patients with pulmonary tuberculosis].
    Blikhar EM; Skakun NP
    Probl Tuberk; 1988; (3):41-4. PubMed ID: 3387393
    [No Abstract]   [Full Text] [Related]  

  • 2. [Essential phospholipids in combined therapy of chronic circulatory insufficiency].
    Golochevskaia VS; Baranskaia EK; Trofimenko IV; Balakhonova NP; Burmakin IA; Kop'ev VI; Zadorozhnaia OO
    Klin Med (Mosk); 1997; 75(5):30-3. PubMed ID: 9235405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of liver damage during a course of tuberculosis and chronic pulmonary diseases. Necessity of treatment and new trends].
    Mariani B; Marchioni GF; Capitolo S
    Minerva Med; 1974 Aug; 65(57):2977-89. PubMed ID: 4603931
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of "Essenciale" in the treatment of liver diseases].
    Pogromov AP; Ol'binskaia LI; Antonenko NI; Gitel' NP; Smolianitskiĭ AIa
    Klin Med (Mosk); 1978 Oct; 56(10):97-101. PubMed ID: 362064
    [No Abstract]   [Full Text] [Related]  

  • 5. [Characteristics of chemotherapy of pulmonary tuberculosis and its effectiveness in patients with diabetes mellitus].
    Karachunskiĭ MA; Adamovich NV; Abdullaev AA
    Probl Tuberk; 1991; (5):31-3. PubMed ID: 1924239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of trofopar, AICA phosphate and Essentiale on the detoxifying function and blood circulation of the liver in lesions in man].
    Nikolaeva AP; Loginov AS; Bendikov EA
    Farmakol Toksikol; 1991; 54(3):56-9. PubMed ID: 1915826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy effectiveness in chronic and hyperchronic forms of destructive pulmonary tuberculosis].
    Kartoziia LS
    Probl Tuberk; 1981 Apr; (4):32-5. PubMed ID: 7255373
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of the preparation essentiale in the therapy of lupus erythematosus].
    Glavinskaia TA; Novikov AI; Pavlova LT
    Vestn Dermatol Venerol; 1983 May; (5):4-7. PubMed ID: 6880388
    [No Abstract]   [Full Text] [Related]  

  • 9. [The clinical pharmacology and efficacy of Essentiale in liver diseases].
    Skakun NP
    Eksp Klin Farmakol; 1993; 56(1):69-72. PubMed ID: 8324485
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rifampicin and ethambutol in treating chronic destructive pulmonary tuberculosis].
    Roslik SM; Iakovleva LM; Zhitnaia VI; Grushevskiĭ ES; Poluianova RP
    Probl Tuberk; 1980 Jun; (6):30-3. PubMed ID: 7393907
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of cholagogic preparations and Essentiale on the natriuretic hormone content of the blood plasma and on kidney function in patients with liver pathology].
    Gapon LI
    Farmakol Toksikol; 1990; 53(4):35-6. PubMed ID: 2226757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lecithin-cholesterol-acyltransferase activity in chronic liver diseases].
    Gaskina TK; Dolgov AV; Kurilovich SA
    Vopr Med Khim; 1987; 33(4):96-9. PubMed ID: 3660750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS; Dzhalalov KD; Blok IuE; Bendikov EA; Ausheva LKh
    Ter Arkh; 1986; 58(2):73-6. PubMed ID: 3704945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary tuberculosis associated with hepatic lesions].
    Ghilean I; Ghilean AM; Lică I
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(1):77-82. PubMed ID: 2990012
    [No Abstract]   [Full Text] [Related]  

  • 15. [Is there an effective therapy for liver diseases? A multicentric clinical study].
    Stoll B; Scholz U; Haase W
    Med Welt; 1976 Apr; 27(15):707-12. PubMed ID: 772360
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of the preparation Essentiale for treating psoriasis patients].
    Abramovich AI
    Vestn Dermatol Venerol; 1984 Jul; (7):54-6. PubMed ID: 6475282
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifampicin--a leading drug in the therapy of tuberculosis not easily amenable to treatment.
    Tousek J
    Respiration; 1971; 28():Suppl:116-22. PubMed ID: 5150791
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of antioxidants on lipid peroxidation and on liver function in patients with pulmonary tuberculosis].
    Skakun NL; Blikhar EI
    Farmakol Toksikol; 1986; 49(5):112-4. PubMed ID: 3770163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Considerations on the treatment with the combination of ribonucleosides, hepatic extract and vitamin B-12 (Nuclepatox) of acute and chronic liver diseases in the course of pulmonary tuberculosis].
    Ravazzoni C; Balzano E; Cuneo S
    Minerva Med; 1967 Jan; 58(6):141-7. PubMed ID: 6016918
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment characteristics of patients with tuberculosis and nonspecific lung diseases complicated by chronic cor pulmonale].
    Petrenko VI
    Vrach Delo; 1983 Mar; (3):82-5. PubMed ID: 6858115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.